David J. Lockhart
2009
In 2009, David J. Lockhart earned a total compensation of $1.1M as Chief Scientific Officer at Amicus Therapeutics, a 14% increase compared to previous year.
Compensation breakdown
| Bonus | $72,100 |
|---|---|
| Option Awards | $632,458 |
| Salary | $360,500 |
| Other | $12,790 |
| Total | $1,077,848 |
Lockhart received $632.5K in option awards, accounting for 59% of the total pay in 2009.
Lockhart also received $72.1K in bonus, $360.5K in salary and $12.8K in other compensation.
Rankings
In 2009, David J. Lockhart's compensation ranked 4,212th out of 9,885 executives tracked by ExecPay. In other words, Lockhart earned more than 57.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,212 out of 9,885 | 57th |
Division Manufacturing | 1,499 out of 3,690 | 59th |
Major group Chemicals And Allied Products | 286 out of 866 | 67th |
Industry group Drugs | 172 out of 638 | 73rd |
Industry Pharmaceutical Preparations | 136 out of 446 | 70th |
Source: SEC filing on April 27, 2012.
Lockhart's colleagues
We found four more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2009.